252-104-2

Applied Filters:

Keyword:'252-104-2'

Showing 1-2 of 2 results for "252-104-2" within Papers

Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.

Kathrin Seidemann et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23(33), 8414-8421 (2005-11-19)

To analyze the association of genetic variation within the tumor necrosis factor (TNF -308 [G-->A]) and lymphotoxin alfa (LT-a +252 [A-->G]) genes with outcome in non-Hodgkin's lymphoma of childhood and adolescence. Genotyping of the TNF -308 (G-->A) and LT-a +252

DNA methylation of microRNA-coding genes in non-small-cell lung cancer patients.

Gerwin Heller et al.

The Journal of pathology, 245(4), 387-398 (2018-03-24)

Deregulated DNA methylation leading to transcriptional inactivation of certain genes occurs frequently in non-small-cell lung cancers (NSCLCs). As well as protein-coding genes, microRNA (miRNA)-coding genes may be targets for methylation in NSCLCs; however, the number of known methylated miRNA genes

Page 1 of 1